Total Funding
59
69
Total FundingSeries B raised
Growth Score 59 in past quarter
-3 pts
Heat Score 69 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
111494
Acornmed provides clinical oncology solutions.
About the Company
Acornmed provides tumor genetic testing and detection solutions intended to provide clinical solutions with genomics as the core of tumor precision medicine. It also provides advanced molecular diagnosis for solid and blood tumor genetic testing, enabling cancer patients to receive comprehensive and personalized early detection test results.